S 545
119th Congress
Senate
Crime and Law Enforcement
Congressional oversight
Consumer affairs
Criminal procedure and sentencing
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Licensing and registrations
Manufacturing
U.S. Sentencing Commission
Veterinary medicine and animal diseases
Combating Illicit Xylazine Act
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 15, 2026
Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.
Apr 15, 2026
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Mar 26, 2026
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Feb 12, 2025
Read twice and referred to the Committee on the Judiciary.
Feb 12, 2025
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.
Hearings & markups
3
- Business meeting to consider S.545, to prohibit certain uses of xylazine, H.R.2159, to direct the Attorney General of t…
- Business meeting to consider S.545, to prohibit certain uses of xylazine, H.R.2159, to direct the Attorney General of t…
- Business meeting to consider the nominations of Melissa Holyoak, to be United States Attorney for the District of Utah …
Related & companion bills
1
Bill text
2 versions
- Introduced in Senate Formatted Text PDF Formatted XML
- Reported to Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
35
D
Merkley, Jeff
R
Cruz, Ted
D
Durbin, Richard J.
R
Blackburn, Marsha
R
Cornyn, John
R
Moody, Ashley
R
Lankford, James
R
McCormick, David
R
Crapo, Mike
R
Justice, James C.
I
King, Angus S., Jr.
R
Budd, Ted
R
Lummis, Cynthia M.
D
Bennet, Michael F.
D
Fetterman, John
R
Tillis, Thomas
D
Gallego, Ruben
D
Blumenthal, Richard
R
Britt, Katie Boyd
D
Cantwell, Maria
R
Capito, Shelley Moore
D
Gillibrand, Kirsten E.
R
Grassley, Chuck
D
Hassan, Margaret Wood
R
Hyde-Smith, Cindy
D
Kaine, Tim
D
Kelly, Mark
D
Klobuchar, Amy
D
Luján, Ben Ray
R
Risch, James E.
D
Rosen, Jacky
R
Scott, Rick
D
Shaheen, Jeanne
R
Wicker, Roger F.
R
Young, Todd
Cite this page
U.S. Congress. (2026). S. 545: Combating Illicit Xylazine Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-545/
"S. 545: Combating Illicit Xylazine Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-545/.
S. 545, 119th Cong. (2026), https://openamerica.io/bill/119-S-545/.
[S. 545: Combating Illicit Xylazine Act](https://openamerica.io/bill/119-S-545/)